MjLink Cannabis Business News and Press
BURLINGTON, Mass., March 16, 2021 – PRESS RELEASE – Agrify Corporation (NasdaqCM:AGFY), a developer of highly advanced and proprietary precision hardware and software grow solutions for the indoor agriculture marketplace, announced it has entered into a binding letter of intent, which sets forth the principal terms of a partnership currently being negotiated with Atlantis Hydroponics to build out a 2,500-square-foot research and development facility. The new R&D facility will be at the Atlantis location in Georgia, where Atlantis has a license to grow hemp in the state.
“At Agrify, we passionately believe indoor, large-scale cultivation is the future of agriculture, and by investing in R&D partnerships, we can continue to foster the necessary data and technology needed to advance the industry,” said David Kessler, chief science officer of Agrify. “We are excited to be potentially working with Atlantis to improve sustainable growing practices while addressing the market need for consistent high-quality products. Our solution works for a wide variety of crops, and we expect that this new facility will help further develop the technology for our offering in the hemp space.”
Atlantis Hydroponics Certified Master Grower Jeremey Doan said, “This collaboration with Agrify is intended to advance our mission to bring self-sustaining gardening practices to the forefront of agriculture and help them become an integral part of our communities. We are dedicated to the manufacturing of great products using a data-first approach, and this facility should enable us to determine how we can grow high-quality, consistent hemp in a future-forward and sustainable manner.”
The R&D facility is expected to focus on increasing concentrations of certain phytochemicals and metabolites (like CBG, CBD, terpenes and flavonoids) via the manipulation and control over abiotic elements in the growing environment, such as temperature and light spectrum. Agrify and Atlantis believe this research will lead to further stabilization and control over the chemotypic expression, and ultimately to safer and more consistent phyto-derived medicines and products. Testing capabilities at the R&D facility will also include mechanical component testing and improvements, new product development evaluation, remote customer “simulation” studies and LED light mapping and evaluation.
The completed R&D facility will be comprised of Agrify’s Vertical Farming Units (VFUs), Integrated Grow Racks (IGRs) and Agrify Insights software platform, and operations are expected to commence in April 2021, subject to entry into a definitive agreement.
]]>Vertical Installation
The use of an energy-saving roller screen system along sidewalls has become an important standard when cultivating crops that require intensive heating. In the past, many growers placed polycarbonate along sidewalls to prevent the loss of precious heat during colder periods. These days, in many new-build and renovation projects, the use of polycarbonate has given way to a movable vertical roller screen system featuring energy-saving screens along sidewalls. The use of a vertical roller screen system also enables multiple (temporary) compartments to be created within a greenhouse. The new transparent RES 10 R FR roller screen system from Ridder is particularly suitable for both applications.
Stable and Flexible
Compared to a conventional horizontal screen system, rolling a wall screen up produces a different type of stress on the screen fabric. This can affect the properties of the screen. Thanks to the flexible but stable structure of the new transparent RES 10 R FR wall screen, the screen properties of the energy-saving fabric remain consistent and reliable. The flexible structure also makes the screen easier to install.
Ideal for Use in Baffle Screens Too
.jpg)
With all the buzz surrounding Delta-8-tetrahydrocannabinol (THC) in the cannabis industry, many questions circulate around what the up-and-coming cannabinoid is, where it comes from, and its legal status.
The National Cancer Institute defined Delta-8-THC in a statement as an analogue of THC that contains neuroprotective properties that can increase appetite and reduce nausea, anxiety and pain. It produces some psychotropic effects that are less potent than Delta-9, the primary form of THC found in cannabis.
Though it is naturally occurring in cannabis, Delta-8-THC can be converted in a lab from cannabidiol (CBD) and Delta-9-tetrahydrocannabinol (THC), says Dr. Ethan Russo, M.D., a board-certified neurologist and founder and CEO of CReDO Science. He says he believes it is most commonly converted from CBD.
Industry stakeholders disagree over if it is federally legal and whether it presents a market opportunity for hemp and cannabis businesses.
Lifted Made, a wholly owned subsidiary of Acquired Sales Corp, entered the Delta-8 market last summer when there were only a handful of brands in it, said Nicholas S. Warrender, vice chairman and COO of Acquired Sales Corp and CEO of Lifted Made.
The nine-member committee entertained two cannabis-related bills during a meeting March 12, including one that would require the state health officer to establish a report on the implementation of a medical program, according to the Wyoming Tribune Eagle. But the other proposal, a full-legalization bill that provides a roadmap to adult-use implementation, won the committee’s endorsement, 6-3.
Sponsored by Republican House Majority Whip Jared Olsen, House Bill 209 includes a 30% excise tax on the sale of adult-use cannabis and cannabis products. Clearing the Judiciary Committee, which Olsen chairs, the bill is now on its way to the House floor for further debate.
According to a fiscal note attached to H.B. 209, the tax would generate in excess of $46 million dollars. Roughly $30.7 million of that revenue would be allocated to public schools through the School Foundation Program fund, and $15.3 million would go to local governments for fiscal 2022, 2023 and 2024—the note did not include projections beyond three years. The Wyoming Department of Revenue derived those estimates from 2020 cannabis sales in neighboring Colorado, adjusting for its own state’s population.
While Wyoming state law currently only allows for the sale and use of cannabidiol (CBD) products, Wyomingites who live in the state’s capital city of Cheyenne are within 10 miles of the fully legalized Colorado border.
Another added revenue stream, the Wyoming Department of Agriculture figures H.B. 209 would generate north of $2 million from licensing fees for the estimated 100 cultivation facilities, 50 manufacturing facilities, 25 secure transporters, five testing facilities, 200 retail stores and 50 microbusinesses per the proposed bill, according to the attached fiscal note.
Colorado State Rep. Yadira Caraveo isn’t sure how the draft version of her cannabis regulatory bill leaked ahead of the 2021 legislative session, but she’s eager for the debate to take shape. Among the legislative proposals is one that’s perked the ears of many in the industry: a 15% cap on THC content.
KOAA reports: “According to Rep. Caraveo, 15% THC was selected as an initial figure because of data from other countries which shows anything greater than 15% can be concerning in terms of effects on the developing brain.”
She acknowledged to the news station that the 15% benchmark is a “starting point” and not something that the industry should expect as the final word in this legislation. Hearings on the bill are under way, with more expected soon.
Watch the full February hearing below.
The main idea, Caraveo said, is to curb effects on underage consumption. She cited anecdotal mental health issues in a February hearing on the bill.
“A lot of things have been said in public, including the inaccurate statement that I’m trying to decimate the industry in Colorado,” she told fellow lawmakers at the time. “That is not my goal. This is the start of a conversation about public health issues that I’m seeing as a doctor and that are being reported not only by CDPHE but by other physicians, parents and advocates who have reached out to me and contributed to my knowledge base on this issue.”
State Rep. Jessica González, a Democrat whose district encompasses parts of Dallas and Grand Prairie, introduced House Bill 3248 on March 8, which aims to allow counties and local municipalities to decide for themselves whether or not to adopt ordinances for adult-use cannabis.
The bill directs the Texas Commission of Licensing and Regulation to adopt the necessary rules to implement, administer and enforce the legislation's health and safety framework, including licensing, regulation, testing standards and transportation, according to a press release from González. The commission would be required to establish those rules no later than July 1, 2022.
H.B. 3248 would impose a 10% tax on the sales price of cannabis products, with 60% of the revenue generated from that tax being allocated to the state’s Foundation School Fund, according to the press release. The remaining revenue would be directed as follows: 20% to participating local governments for the purpose of oversight; 10% to cannabis testing and quality control; and 10% to cannabis regulation.
“[Fifteen] states in America have legalized cannabis, and 26 total states have decriminalized the use of cannabis,” González said. “In a recent study, 54% of Texans supported the legalization of recreational cannabis use. While Texas has made progress with the Compassionate Use Act, we have been left behind on a potential revenue source that would increase investments in public education, stop the unnecessary arrests for cannabis possession and create jobs in our state. We should allow our local communities to make the best decision for themselves in regards to cannabis legalization, and H.B. 3248 would allow that for adults 21 years or older.”
The Compassionate-Use Program is the law that governs the medical use of low-THC cannabis by patients diagnosed with seizure disorders, multiple sclerosis, spasticity, terminal cancer and other ailments. But the program’s pitfalls, like restrictions on where companies can store their inventory, came to light during a widespread winter storm that left delivery drivers immobilized by hazardous road conditions last month.
As cannabis prohibition and criminalization has negatively impacted many Californians and California communities, the state’s Governor’s Office of Business and Economic Development (GO-Biz) partnered with the Bureau of Cannabis Control (BCC) to provide $15 million in grant funding to help those caught in the sightlines of the war on drugs, building upon the $40 million in cannabis equity funding previously awarded by the state.
GO-Biz and BCC announced Monday that the Cannabis Equity Grants Program for Local Jurisdictions will distribute the funds. The grants program works to improve economic justice for populations and communities impacted by cannabis prohibition by providing funding to local jurisdictions committed to promoting equity in the legal cannabis marketplace and eliminating barriers to entering the regulated cannabis industry.
Individuals convicted of a cannabis offense have a hard time entering the cannabis industry due to lack of resources, including the capital, business space, technical support and regulatory compliance assistance, the release states.
The jurisdictions will use the funding to advance cannabis equity programs, part of a broader effort to create a diverse legal industry. It will also aid program applicants and licensees by providing waived or reduced licensing fees, low- or no-interest loans or grants, and technical assistance like one-on-one consulting, training and navigation assistance with cannabis licensing and regulatory requirements, according to the release.
“As we work to safely reopen our economy, leading with equity across all sectors will ensure a just recovery and further our commitment to create a truly diverse legal industry,” said Nicole Elliott, senior adviser on cannabis to Gov. Gavin Newsom. “These efforts stand as a testament to our values as a state, and I applaud the work being done by these jurisdictions as they thoughtfully embrace this challenge.”
And the state’s previous funding efforts have made a memorable impact on businesses. The CEO of Green Peakz, Jessie Grundy, said the California Cannabis Equity grant he received was “one of the best things to happen to his company.”
This is a story about heat and pressure.
And cannabis.
Centuries ago, the original cannabis concentrates were made using hand-pressed hashes, with communities on the Indian subcontinent using their hands to make charas. To use modern lingo, these were solventless concentrates, not all that different from products that consumers are finding on dispensary shelves today.
“The origins of solventless go all the way back to the beginning of when hash was first discovered,” Eric Vlosky, PurePressure’s director of marketing and business development, says.
In the 1980s and ‘90s, bubble hash had a moment in traditional cannabis markets before butane extraction gained a certain prominence in the 2000s and into the 2010s. In 2014, Phil “SoilGrown” Salazar used his girlfriend’s hair straightener to squeeze a cannabis bud and noticed an enticing oil spilling out. Here we have the creation of modern rosin. The solventless extraction industry has grown steadily ever since.
In 2015, PurePressure was formed to address this new demand. Co-founders Josh Rutherford and Ben Britton worked together to engineer a better press than what was on the market at the time (mostly repurposed T-shirt presses). The original prototype worked exceedingly well, and the company was off to the races.
In the solventless extraction process, even more so than in hydrocarbon extraction, the quality of the input material is paramount. Because the live rosin end product contains the very essence of the plant that went into the press, it’s vital for operators to seek out the very best genetic lines and cultivars and the most freshly dried and cured plant material.
More specifically, the key is in the trichomes.
Solventless operators will typically find that trichomes in the 90- to 120-micron range make up the cream of their crops. The size will make it easier to capture the resin within during the pressing process. (This is why, on a related note, hemp varieties and cannabis trim tend not to work well with ice water hash washing, but do better with dry sifting.)
Cultivars (and genetics families) that tend to do well in the solventless process include: Chem strains, Papaya strains, Cake strains, Cookies and Cream, GMO, Banana OG, Do-Si-Dos, MAC, Tropicana Cookies, and many others with new winners seemingly being found daily. The bottom line: These cultivars are heavy resin-producers, often in the traditional “indica” or “hybrid” categories.
“When it's pressed well, you tend to get the most original expression that the plant has to offer because it hasn't been modified by all kinds of super high pressures and solvents taking things apart and putting it back together,” Vlosky says.
This is why top-notch plants are critical.
LAS VEGAS, March 15, 2021 – PRESS RELEASE – Planet 13 Holdings Inc. (CSE:PLTH)(OTCQB:PLNHF), a leading vertically integrated Nevada cannabis company, announced that Select, known as America’s No. 1 cannabis oil brand, has partnered with Planet 13 to create a unique shop-in-shop experience, highlighting the Select brand in the Las Vegas SuperStore. The shop-in-shop, which will occupy prime space within the Planet 13 Las Vegas SuperStore dispensary, will host its grand opening on March 15th and will be staffed by Select team members. The Select store will act as a sales and education platform, introducing Select’s many award-winning and industry-leading products to millions of visitors.
Select has earned its place as an industry leader by setting stringent quality standards and focusing on the relentless pursuit of progress and innovation. Known for quality and expertise, Select provides industry-leading service, product selection and accessibility to both medical and adult-use customers in 17 states across the U.S. Select’s shop-in-shop at Planet 13 is a one-of-a-kind experience that will showcase the brand’s entire portfolio of products including Select Elite, Select Elite Live, Select Classic Bites, Select Nano Gummies and Select Ratio Drops. The Las Vegas SuperStore will be among the first retailers in the state to carry Select’s newest offerings throughout 2021.
“We are excited to partner with Curaleaf to create an exceptional showcase for their popular Select brand,” said Bob Groesbeck, co-CEO of Planet 13. “Planet 13’s tourist-friendly, experiential store is the perfect place to introduce top cannabis brands to both new and existing cannabis users.”
Patrick Larkin, senior vice president of sales at Curaleaf, said, “The Select and Planet 13 partnership is an embodiment of how we are actively investing in our retail partners and elevating our retail presence with the goal of enriching the experiences of our customers. The Planet 13 Las Vegas SuperStore is well-known as an international tourist destination, and we welcome the opportunity to introduce customers from across America and the world to America’s first national cannabis brand.”
For more information on Planet 13, visit the investor website.
For more information on Select, visit www.selectbetter.com.
]]>Senate Majority Leader Michael J. McCaffrey and Democratic colleague Sen. Joshua Miller introduced Senate Bill 568 March 9, which outlined the details of possession, taxing, local participation, home grows, social equity and retail, as well as establishing a five-member Cannabis Control Commission to oversee licensing.
“The act further provides for the creation of [a] social equity assistance fund and program to be funded by licensing and renewal fees, as appropriated,” the bill states. “The act also provides for an expedited expungement procedure for prior cannabis arrest and convictions involving 1 ounce or less of cannabis.”
The bill’s 11-tier licensing system costs for cultivators would range from $100 for up to 1,000 square feet of outdoor grows, to $20,000 for indoor grows between 90,000 and 100,000 square feet. Other annual licensing fees include $5,000 for manufacturers, $5,000 for independent testing laboratories and $20,000 for retailers, according to the bill.
Additional revenue would come in the form of a 20% tax on retail sales, which breaks down to a 10% cannabis excise tax, a traditional 7% sales tax and a 3% local sales tax that would stay in the city or town where the point of sale occurred, according to the bill. Local municipalities could opt out of issuing retail licenses, if voters adopt a ballot measure that prohibits dispensaries in their communities.
“We want to provide cities and towns with the ability to opt out, but we cannot allow an overly burdensome patchwork of regulation throughout our state,” McCaffrey said in a press release. “We know from experiences in other states that less parochialism and lower fees leads to greater transparency and a more competitive market. If a community wants to opt out and forgo tax revenue that is one thing, but we also need to make sure the process is open and transparent.”
The possibility of a new and massive cannabis market sprang into being this week as Mexico’s Lower House of Congress approved a decriminalization and legalization bill, which is widely expected to become law in the near future. It’s a development that will dramatically alter the global cannabis landscape, giving multinational businesses a new outlet for growth and product innovation.
Here are some of the key headlines from this past week:
Mexico's Chamber of Deputies passed a cannabis decriminalization and legalization bill March 10 with a 316-129 vote. It now moves onto the Senate, where several amendments must be formally approved. Read moreThe race is on between legislative bodies in Minnesota, as state lawmakers consider lifting a medical ban on smokable flower at the same time as passing an adult-use bill. Read more
International Women’s Day kicked off this week on March 8, and Assistant Editor Andriana Ruscitto provides insight from leaders in the business. “This is the most exciting evolving, changing, industry to date, and we all have the opportunity to build it and shape it for what it is,” one cannabis founder says. Read more
The U.S. welcomes a new attorney general with the formal confirmation of Merrick Garland. We take a look at what that means for cannabis. Read more And in Kentucky, it’s still a long road to medical cannabis legalization. Read more
And elsewhere on the web, here are the stories we’ve been reading this week:
WOWT: “If you legalize marijuana, you're going to kill your kids." So says Nebraska Gov. Pete Ricketts ahead of a state hearing on medical cannabis legalization. Read more Hollywood Reporter: “Seth Rogen's newly launched cannabis lifestyle brand site, Houseplant, crashed Thursday due to the overwhelming demand. The site was so inundated, Rogen said it needed to be taken down temporarily.” Read moreMassLive: SeaWood Co. opened the first adult-use dispensary in Portland, Maine. Read more
Reuters: Thai businesses are moving fast to capitalize on new hemp and CBD laws. Read more
Ganjapreneur: South Dakota is moving forward (again) on its medical cannabis legalization, hung up by a state legislature dispute. Read more
]]>
In the state Senate, the Health and Human Services Finance and Policy Committee amended and unanimously voted, 9-0, to pass Senate File 1179 earlier this month, which includes provisions to modernize a 5-year-old medical cannabis program that currently bans manufacturers from providing dried leaf and flower for qualifying patients to smoke.
As the law stands in Minnesota, only oils and tinctures containing tetrahydrocannabinol (THC) can be consumed, which are typically more expensive than smokable flower. That has left medical cannabis patients spending more money out of pocket or, perhaps, the inclination to pursue the illicit market. According to the Minnesota Department of Health, the average cost for a 30-day supply of medical cannabis was $316 in 2019.
The goal of S.F. 1179 is to make medical cannabis more affordable and more accessible to qualifying patients, Sen. Mark Koran told the MinnPost earlier this month. A Republican, Koran authored the bill.
In addition to allowing the state’s two manufacturers—LeafLine Labs and Vireo Health of Minnesota—to cultivate and distribute dried flower for smoking, other key provisions in the bill include adding opioid addiction as one of the nine qualifying health conditions, and a process for adding a delivery method for the medical program’s 11 distribution clinics in the state.
But S.F. 1179 is not a path to full legalization, as there’s a different finish line brewing in the land of 10,000 lakes.
Even for casual fans, the high-pitched, nasally flow of Cypress Hill’s lead vocalist is instantly recognizable. B-Real has been a legendary figure in hip-hop and cannabis for decades. Now that his Dr. Greenthumb dispensary franchise is quickly expanding across southern California, the voice behind classics like “Hits from the Bong” and “Insane in the Membrane” has a lot to say about the business of weed.
Cannabis Business Times and Cannabis Dispensary spoke to B-Real via phone to get his thoughts on the state of the game and what should happen next:
Raj Chander: Lots of corporate multi-state operators (MSOs) are getting into the cannabis industry, but many consumers have questioned their authenticity. How do we strike a balance between supporting business while staying true to the plant?
B-Real: There’s definitely a balance, ... but some of these brands that have come in, celebrity brands and big corporate brands, they’ve yet to find that middle ground. The one thing we know about the cannabis industry is people want to know you’ve been in the industry at any point—could be advocacy, activism, or actually someone in the culture who was cultivating. ... They want to know that you’ve actually been involved in the culture and it’s not just a money grab. And unfortunately, for a lot of corporate entities coming in, it’s a money grab, and it’s perceived as that, and some of those brands sort of fall by the wayside no matter how much money they’ve thrown at promoting and hyping up said brand. I think you see a lot more corporate entities doing deals with brands with names now to get into the industry, to get into the culture.
Anyone coming in trying to create their own brand has had a harder time. ... You have to figure out how you can engage these folks and make them familiar with your brand, and make sure that your brand quality lives up to the hype. In the last couple years we’ve seen a couple brands that have so much money to spend on marketing to be one of the most sought out brands, and when you get to their dispensary or you buy one of their products, it just does not meet the mark. Plenty of places are great in their visibility, but what they put on their counters isn’t living up to anyone’s expectations.
RC: California in particular is facing a huge issue right now with the legacy market. Why has this been such an issue, and what do you think can be done to correct it?
In honor of Women’s History Month and International Women’s Day on March 8, 2021, three successful women in the cannabis space share their journey, challenges and advice for working in the industry.
A woman who has impacted the industry is Lilach Mazor Power, founder and managing director at Giving Tree Dispensary, the only dispensary in Arizona with majority female ownership.
Power entered the cannabis industry in 2013 when there were little to no experts in the space. She had to make several sacrifices and worked for free for years, as she knew the company had to continue growing, she said.
But one of the most important things is that she was not afraid to jump in, take risks and work hard to get to where she aspired to be. Someone who can relate to that is Michelle Hackett, president of Riverview Farms in California.
In 2016, Hackett entered the industry when her father, Mike, was one of the first farmers permitted a license to grow medical cannabis in California. Her father wanted to take the business further than cultivation and turn it into a full seed-to-sale business. So, she left her job and jumped on board to help her father build the company, she said.
“At the start of legalization and coming into this space, there was little to no structure,” Hackett said. “We really built the business from the ground up through trial and error.”
By a vote of 70-30, the U.S. Senate today confirmed Merrick Garland to be U.S. Attorney General. While, prior to his confirmation, the new Attorney General had not been outspoken about cannabis, federal prosecution of marijuana-related crimes, or the federal-state divide over the legality of cannabis, Attorney General Garland did offer the state-legal cannabis industry in the United States reason for optimism during his recent confirmation hearings.
Most notably, responding to a question from Sen. Cory Booker (D-NJ) concerning potentially reissuing the Cole Memorandum, then-Judge Garland, testified that he did not think it was a “useful use” of limited federal resources to prosecute most cannabis-related conduct:
This is a question of the prioritization of our resources and prosecutorial discretion. It does not seem to me a useful use of limited resources that we have, to be pursuing prosecutions in states that have legalized and that are regulating the use of marijuana, either medically or otherwise. I don’t think that’s a useful use.
I do think we need to be sure there are no end-runs around the state laws that criminal enterprises are doing. So that kind of enforcement should be continued. But I don’t think it’s a good use of our resources, where states have already authorized. That only confuses people, obviously, within the state.
The Cole Memorandum was prepared in 2013 by then-Deputy U.S. Attorney General James M. Cole. It offered “Guidance Regarding Marijuana Enforcement,” identified several federal “enforcement priorities,” and provided that the federal government generally would refrain from prosecuting marijuana-related offenses unless they implicated one of those enforcement priorities.
As of Wednesday morning, the Lower House of Mexico’s Congress was planning an imminent floor vote on a sweeping cannabis decriminalization and legalization bill. The legislation cleared two key committees on Tuesday, setting up an important vote on what could quickly become the world’s largest legal cannabis market.
The proposed law is supported by President Andrés Manuel López Obrador and the governing Morena party.
In 2018, Mexico’s Supreme Court ruled that an absolute ban on recreational use of marijuana was unconstitutional. Thus began the formal effort to legalize cannabis, which brings us to today’s planned vote. The country’s judicial branch has exerted influence on the process, giving legislators a deadline (extended to April 2021) to pass a bill and legalize a regulated industry around the cannabis plant.
The recent delays came out of ongoing debate over that regulatory structure: How should this new industry be arranged for the most comprehensive social and economic benefit?
The full text of the bill is embedded below.
The bill would kick regulatory authority to the existing National Commission Against Addictions (rather than a new agency, as previously stipulated in earlier versions of the bill). Licensing categories would include cultivation, transformation, sale, research and export or import. As written currently, the bill would allow anyone 18 or order to pursue a permit not only to consume and possess cannabis (up to 28 grams at a time) but to work in the industry as well.
Offering a different take on beverages such as beer, coffee and lemonade, brands are serving cannabis consumers with tetrahydrocannabinol (THC) and cannabidiol (CBD) in drinkable form.
One of Canada’s licensed producers (LPs), publicly traded Canopy Growth, which has infused and sold beverages in Canada over the past year, is now bringing its beverages below the border to the U.S. It’s starting with flavored cans of sparkling water with 20 milligrams of CBD that it’s marketing under the Quatreau brand.
“The North American market potential for CBD-infused beverages is extremely promising, and with the continued growth the industry is seeing, we know it has the potential to really disrupt other traditional beverage formats, from sparkling water and soda to beer, wine and spirits,” said Tara Rozalowsky, Canopy’s vice president of beverages and edibles.
RELATED: THC-Infused Tonics Find Their Place in Cannabis Beverage Market in 2020
Rozalowsky said Canopy sees the opportunity to enter the U.S. CBD beverage space due to its large size, experience manufacturing hemp products, ability to scale, and understanding of industry regulations.
The chances of legalizing medical cannabis in Kentucky are low in 2021, as reported in The Ledger Independent.
Earlier this year, Kentucky Rep. Jason Nemes introduced House Bill 136, and, following that, Kentucky Sen. Steve West introduced Senate Bill 92.
The bills would help establish a medical cannabis program in the state. If passed, practitioners would be able to recommend medical cannabis to patients, and the cultivation, manufacturing, distribution, delivery, transportation, testing, preparation, packaging for sale, and sale of medical cannabis in Kentucky would be legal, the news outlet reported.
According to the report, the bills have remained in the committees and did not move in either chamber this year. And Kentucky Rep. William Lawrence, a co-sponsor on H.B. 136, said the bills are likely to go into next year’s legislative season.
His support for H.B. 136 remains strong, as he stated he thinks legalizing medical cannabis will tremendously help patients who are struggling. He also said the bill could open the job market and create a new revenue stream for farmers.
But due to the COVID-19 pandemic and the economic crisis it caused, Lawrence stated that many leaders focused on getting through that, and legalizing medical cannabis was not a priority this year; however, he is hopeful that it will get through during the 2022 legislative season.
]]>TORONTO, March 4, 2021 – PRESS RELEASE – Marketing cannabis in Canada is a complex process, and rightly so, but, making it one step easier to navigate, Duallok announced the expansion of its child-resistant packaging inventory to Toronto.
Already available in the U.S. out of Los Angeles and New Jersey, this new inventory location makes a speedy and safe packaging solution accessible to an even wider geographic. Presenting an immediately available rolling stock of child-resistant packaging in its most popular format, Duallok inventory is suitable for a wide range of products enabling cannabis brands to move quickly to market.
So how does it work? The Duallok patented double-lock design is certified under the 16 Code of Federal Regulations (CFR) 1700 guidelines for child resistance, meaning companies can take products to market knowing confidently that they are also keeping kids safe and their brand compliant.
Based in these three prime locations are a large inventory of unbranded black and white packages ready to customize as needed to meet local legislation for vape carts, pre-rolls, edibles and much more.
Once a company selects its choice color and unit quantity, the packs are available for collection or dispatch in just two to three business days and fit directly into a company’s existing packaging process. No need to provide artwork or prepare labelling, these packs are ready to ship directly to you.
Duallok partners, stationed across the U.S. and Canada, can also support companies with any additional requirements for bespoke internal product fitments or further customizations. It's a streamlined process with a dedicated project manager ready to help at every stage.
